OLFM4 and Alzheimer disease: showed that inhibition of olfactomedin 4 (OLFM4) also promotes bacterial clearance by neutrophils.[41] As a result, we conjecture that OLFM4 may be an interesting target for AD treatment or healthy cognitive aging.